Research Article | Open Access
Asma Aiza1,2,3 , Rachid Kaidi1,2, Moussa Ahmed4 and Baghdad Khiati4,5
1Laboratory of Biotechnologies related to Animal Reproduction, Blida 1 University, Blida, Algeria.
2Institute of Veterinary Sciences, Blida 1 University, BP 270, Ouled Yaich, 9000 Blida, Algeria.
3Departement of Agronomic Sciences, Djilali Bounaama University, 44225, Khemis Miliana, Algeria.
4Institute of Veterinary Sciences, Ibn Khaldoun University, Tiaret, 14000, Algeria.
5Laboratory of Improvement and Valorization of Local Animal Productions, Ibn Khaldoun University, Tiaret, Algeria.
Article Number: 8756 | © The Author(s). 2023
J Pure Appl Microbiol. 2023;17(3):1628-1640.
Received: 07 June 2023 | Accepted: 24 July 2023 | Published online: 01 September 2023
Issue online: September 2023

The present study was carried out between 2016 and 2020 in Makour Hamou Public Hospital, Ain Defla district, North Centre of Algeria. The study aimed to characterise the antimicrobial resistance and multidrug resistance in bacteria isolated from 620 patients with purulent skin wounds. Out of the 428 bacterial isolates, 283 were Gram-positive (66.12 ± 4.48%) (P<0.001). A total number of 77 Staphylococcus aureus isolates were obtained, among them 31.2 ± 9.3% (24/77) were methicillin-resistant. The most frequent Gram-negative bacteria were Escherichia coli (30.34±7.4%), followed by Klebsiella pneumoniae (25.52±7.10%), and Pseudomonas aeruginosa (23.45±6.70%). All Staphylococcus aureus isolates (77/77) were sensitive to clindamycin. Escherichia coli isolates were resistant to several antibiotics with high resistance rates to amoxicillin (38/44; 86.4 ± 10.1%), amoxicillin-clavulanate (30/44; 68.2 ± 13.8%), cefazolin (21/44; 47.7 ± 7.5%) and trimethoprim-sulfamethoxazole (16/44; 36.4 ± 14.2%) (P<0.001). All Gram-negative bacteria were sensitive to amikacin (145/145) and only one Gram-positive isolate (99.65 ± 0.69%) was resistant to vancomycin. Multidrug resistance was observed in 31.54% of isolates; it was significantly higher in Gram-negative compared to Gram-positive bacteria (62/145; 42.76 ± 8% and 73/283; 25.79 ± 5.10%, respectively) (P<0.001). Multidrug resistance rate was significantly correlated to patients’ age (P<0.001) but not according to years. These results showed the presence of different bacteria species from human wound infections. The resistance to one or multiple antibiotics were frequent. It is recommended to reduce irrational use of antibiotics and a more frequent use of antibiogram before any antibiotic prescription.


Multidrug Resistance, Antibiotic Susceptibility, Pus, Wound, Algeria


Antibiotic resistance is a critical cosmopolitan public health issue causing increasing serious public concerns. The emergence of multidrug resistant bacteria is increasingly common and represents a threat in all over the world.1-3 This bacterial resistance is the main cause of a multitude of difficult-to-treat wound infections.4 Several epidemiological studies showed important fluctuations in antibiotic resistance according to the nature of wounds, surgical procedures, and regions.5 Different patterns of bacteria such as staphylococci, Enterobacteriaceae, and Pseudomonas, cause of pus infections.

Depending on the causative bacteria, active infections are either purulent or serosanguinous.6 These pyogenic infections interfere with the wound healing process, leading to a dramatic increase of treatment costs, morbidity, and mortality.7,8 Bacteria identification, to the level of species and strain, and monitoring of the organisms’ response to the therapeutic protocol require microbiological research implementation in both surgery and pharmacology 6. Knowing the local epidemiology and the antibiotic resistance pattern will therefore help decreasing treatment failure risks.7 The intensive uncontrolled use of antibiotics increases microbial resistance rate and speed. This resistance induces the development of chronic wounds and in extreme cases stops the healing.9

In the world, several research were conducted to estimate the frequency of pyogenic infections, causative bacteria, and their antibiotic susceptibility. Different wound infection rates were reported in several countries. It was reported to be low in France (2.2%) 10 but very high in developing countries such as Sudan (25.23%).11

In Algeria, the incidence of methicillin-resistant S. aureus (MRSA) isolated from surgical site infections between 2008 and 2010 was estimated to 4.2%.12 In the north west of Algeria, Bouharkat et al reported that 18.3% of the 60 S. aureus isolates were MRSA.13 However, there is lack of information regarding bacterial resistance evolution in Algeria.

The present study aimed to investigate antimicrobial resistance patterns, including multidrug resistance, among bacteria isolated from various types of pyogenic infected wounds in humans in Makour Hamou Hospital in Ain Defla, Algeria.

Materials and Methods

Samples’ collection
The present study was a prospective investigation. It was carried out during five years, from the 1st of January 2016 to the 31st of December 2020 in Makour Hamou public hospital, Ain Defla district, North Centre of Algeria. A total of 620 patients consisting of 262 males and 358 females (sex ratio M:F = 0.73) presenting wound purulent infections and at least one of the wound infection symptoms were including in the sampling.14 The patients’ ages ranged from one month to 90 years (mean age: 37.7±20.69 years).

Pus/wound samples were collected aseptically using disposable sterile swabs or syringes. The samples were identified and immediately transported to the laboratory of medical analyses. To prevent duplicate samples, each patient was included in the study only once during their entire hospitalization period.

Bacterial isolation and identification
The samples were primarily cultivated using standard media: blood agar, Mannitol salt agar, and Hekteon agar (Tmmedia Labs, Rajasthan, India) and incubated at 37°C for 24-48 h. Blood agar plates were incubated in an atmosphere rich in CO2. In the case of a polymicrobial culture, distinct colonies were randomly selected and streaked into new plates until pure cultures were obtained. The identification was made according to standard bacteriological diagnostic procedures: macroscopic examination of colonies, unstained wet-mount test, Gram staining, and biochemical tests. Control strains as E. coli (ATCC 25922), S. aureus (ATCC 25923), and P. aeruginosa (ATCC 27853), were included in the study.

Antimicrobial susceptibility testing
Antibiotic susceptibility test was performed using Muller-Hinton agar (Tmmedia Labs, Rajasthan, India) plates by disk diffusion method according to Guidelines of Clinical and Laboratory Standards Institute.15 A total number of 26 antibiotic discs (Cypress Diagnostic, Langdrop, Belgium) were used to test antibio-susceptibility of the strains (Table 1).

Table (1):
Antibiotics tested for antibioresistance of bacterial strains isolated in the present study (antibiotics are listed alphabetically)

Antibiotic (disc content) Gram-negative bacteria Gram-positive bacteria
Enterobacteriaceae species Pseudomonas spp. Staphylococcus spp. Streptococcus spp. and Enterococcus spp.
Amikacin (30 µg)
Amoxicillin (10 µg)
Amoxicillin-Clavulanate (20/10 µg)
Aztreonam (30 µg)
Cefazolin (30 µg)
Cefotaxime (30 µg)
Ceftazidime (30 µg)
Ciprofloxacin (5 µg)
Clindamycin (2 µg)
Doxycycline (2 µg)
Erythromycin (15 µg)
Fosfomycin (200 µg)
Gentamicin (10 µg)
Imipenem (10 µg)
Nalidixic Acid (30 µg)  
Netilmicin (30 µg)  
Nitrofurantoin (300 µg)
Ofloxacin (5 µg)
Penicillin (10 UI)
Piperacillin (100 µg)
Rifampicin (30 µg)
Ticarcillin (75 µg)
Ticarcillin-Clavulanate (75/10 µg)
Tobramycin (10 µg)
Trimethoprim-Sulfamethoxazole (1.25/23.75 µg)  
Vancomycin (30 µg)



Methicillin-resistant S. aureus was detected by disc diffusion test using cefoxitin (30 µg) on Muller-Hinton Agar. Bacteria producing Extended-Spectrum b-lactamases (ESBLs) were screened using disc diffusion on Muller-Hinton Agar and confirmed by double disc method (Amoxicillin-Clavulanate (20/10 µg)/Cefotaxime (30 µg)).15

As recommended by the international expert for standard, multidrug resistance (MDR) was defined as acquired non-susceptibility to at least one antibiotic from at least three antimicrobial groups.16

Data analysis
All data were analysed in a Microsoft Excel® 2019 spreadsheet. Percentages were compared using chi-square test at 5% threshold with Epi info 2000 software.17


Description of the study population
Between 2016 and 2020, 620 pus samples were collected from different types of infected wounds where the highest number of samples was collected during 2017 (160/620; 25.81 ± 3.44%). More than half (373/620; 60.16 ± 3.85%) of the infected wounds were collected between October and April, corresponding to the cold months (P<0.001) (Table 2). The highest number of samples was collected from patients aged between 30 and 35 years (76/620; 12.26 ± 2.58%), followed by [35-40[age group (66/620; 10.65 ± 2.43%) and finally [25-30[age group (54/620; 8.71 ± 2.22%) (Figure 1).

Table (2):
Characteristics of the studied human population in the present study

(% ± SE)
(42.26 ± 3.89)
(57.74 ± 3.89)
(13.06 ± 2.65)
(25.81 ± 3.44)
(23.06 ± 3.32)
(17.26 ± 2.98)
(20.81 ± 3.20)
(60.16 ± 3.85)
(39.84 ± 3.85)


Figure 1. Number of pus samples collected in the present study according to age category

Bacterial species
Among the 620 cultivated swab samples, 407 were positive (65.65 ± 3.74%) totalling 428 bacterial isolates. Among the positive samples, 21 showed mixed cultures (5.16 ± 4.86%).

Gram-positive bacteria (283; 66.12 ± 4.48%) were significantly more frequent than Gram-negative bacteria (145; 33.88 ± 4.48%) (P<0.001). The majority of Gram-negative bacilli were Escherichia coli (E. coli) (44/145; 30.34 ± 7.48%) followed by Klebsiella pneumoniae (K. pneumoniae) (37/145; 25.52 ± 7.10%) and P. aeruginosa (34/145; 23.45 ± 6.70%) (P<0.001). Coagulase-negative staphylococci (CoNS) were the most frequent (154/283; 54.42 ± 5.80%) Gram-positive cocci, followed by S. aureus (77/283; 27.21 ± 11.21%) and Streptococcus spp. (49/283; 17.31 ± 4.41%) (P<0.001) (Figure 2).

Figure 2. Frequency of bacteria isolated in the present study from pus/wound samples

Antimicrobial resistance patterns
Among the 77 S. aureus isolates, the highest rate of resistance was for penicillin (54/77; 70.1 ± 10.2%), followed by doxycycline (21/77; 27.3 ± 10%), and gentamicin (16/77; 20.8 ± 9.1%) (P<0.001). High susceptibility rates of 91.7% and 100% were observed for clindamycin and vancomycin, respectively. Finally, almost one third (24/77; 31.2 ± 9.3%) of S. aureus isolates were MRSA. CoNS isolates were resistant to penicillin (135/154; 53.60 ± 7.88%), erythromycin (65/154; 32.47 ± 7.40%), and doxycycline (62/154; 26.62 ± 6.98%) (P<0.001).

Ticarcillin (19/49; 38.8 ± 13.6%), clindamycin (15/49; 30.6 ± 12.9%), and erythromycin (14/49; 28.6 ± 12.6%) had the highest resistance rates in Streptococcus spp. isolates (P<0.001).

Escherichia coli isolates were resistant to several antibiotics, particularly amoxicillin (38/44; 86.4 ± 10.1%), amoxicillin-clavulanate (30/44; 68.2 ± 13.8%), cefazolin (21/44; 47.7 ± 7.5%) and trimethoprim-sulfamethoxazole (16/44; 36.4 ± 14.2%) (P<0.001).

Klebsiella pneumoniae showed high resistance rates to amoxicillin (36/37; 97.3 ± 5.2%), amoxicillin-clavulanate (31/37; 83.8 ± 11.9%), cefazolin (25/37; 67.6 ± 15.1%), and cefixime (18/37; 48.7 ± 16.1%) (P<0.001). P. aeruginosa isolates were most resistant to piperacillin (13/34; 38.2 ± 16.3%), ticarcillin (10/34; 29.4 ± 15.3%), ticarcillin-clavulanate (6/34; 17.7 ± 12.8%), and netilmicin (5/34; 14.7 ± 11.9%) (P<0.001).

Four isolates were ESBL positive, consisting of three (3/37; 8.1%) K. pneumoniae and one (1/44; 2.3%) E. coli isolates. All Gram-negative bacteria were sensitive to amikacin (145/145) followed by imipenem (98.62 ± 1.9%; 143/145). Vancomycin is the most effective antibiotic against Gram-positive bacteria showing 99.65+/-0.69% (282/283 strains) of susceptibility rate (Table 3).

Table (3):
Antibiotic resistance pattern of bacterial strains isolated in the present study

Bacterial isolate (number) CoNS
S. aureus
Streptococcus spp.
Enterococcus spp. (N=3) E. coli
Klebsiella pneumoniae
P. aeruginosa
P.  fluorescens
Proteus Vulgaris
Proteus mirabilis
Other Enterobacteriaceae
Antibiotic tested (number of resistant strains (%±SE)
PEN 81/154 (52.60 ± 7.89) 54/77 (70.13 ± 10.2) 3/49 (6.1 ± 6.7) 3/3
GEN 6/154 (3.90 ± 3.06) 16/77 (20.78 ± 9.06) 4/44 (9.1 ± 8.5) 5/37 (13.5 ± 11) 1/34 (2.9 ± 5.7) 0/4 0/10 0/9 2/7
AMK 5/154 (3.25 ± 2.80) 11/77 (14.29 ± 7.82) 0/44 0/37 0/34 0 /4 0/10 0/9 0/7
ERY 50/154 (32.47 ± 7.4) 15/77 (19.48 ± 8.85) 14/49 (28.7 ± 12.7) 0/3
CLI 11/154 (7.14 ± 4.07) 5/77 (6.49 ± 5.50) 15/49 (30.6 ± 12.9) 1/3
VAN 0/154 0/77 0/49 1/3
OFX 12/154 (7.79 ± 4.23) 14/77 (18.18 ± 8.61)
SXT 36/154

(23.38 ± 6.68)

6/77 (7.79 ± 5.98) 16/44 (36.4 ±14.2) 15/37 (40.5 ± 15.8) 6/10 2/9 5/7
DOX 41/154 (26.62 ± 6.98) 21/77 (27.27 ± 9.95)  –
RIF 1/49 (2.0 ± 4) 0/3
AMX 1/49 (2 ± 4) 3/3 38/44 (86.4 ± 10.1) 36/37 (97.3 ± 5.2) 10/10 7/9 6/7
AMC 30/44 (68.2 ± 13.8) 31/37 (83.8 ±) 5/10 4/9 5/7
CFZ 21/44 (47.7 ± 14.8) 25/37 (67.6 ± 15.1) 3/10 2/9 5/7
CTX 11/44 (25 ± 12.8) 14/37 (37.8 ± 15.6) 2/10 0/9 5/7
IPM 0/44 0/37 2/34 (5.9 ± 7.9) 0/4 0/10 0/9 0/7
FOF 0/44 2/37 (5.41 ± 7.3) 1/10 1/9 3/7
CIP 6/44 (13.6 ± 10.1) 4/37 (10.81 ± 10.01) 0/34 0/4 0/10 0/9 4/7
NAL 14/44 (31.8 ± 13.8) 6/37 (16.2 ± 11.9) 2/10 2/9 6/7
NIT 11/44 (25 ± 12.80) 16/37 (43.24 ± 15.96) 6/10 8/9 4/7
TIC 10/34 (29.4 ± 15.3) 2/4
TIM 6/34 (17.7 ± 12.8) 1/4
PIP 13/34 (38.2 ± 16.3) 1/4
CAZ 4/34 (11.8 ± 10.8) 0/4
NET 5/34 (14.7 ± 11.9) 0/4
TOB 3/34 (8.8 ± 9.5) 0/4
ATM 2/34 (5.9 ± 7.9) 0/4
MDR 34/154 (22.08 ± 6.55) 31/77 (40.26 ± 10.96) 8/49 (16.3 ± 10.3) 0/3 22/44 (50 ± 14.8) 20/37 (54.1 ± 16.1) 3/34 (8.8 ± 9.5) 0/4 7/10 4/9 6/7

Penicillin (PEN); Gentamicin (GEN); Amikacin (AMK); Erythromycin (ERY); Clindamycin (CLI); Vancomycin (VAN); Ofloxacin (OFX); Trimethoprim+ Sulfamethoxazole (SXT); Doxycycline (DOX); Rifampicin (RIF); Amoxicillin (AMX); Amoxicillin Clavulanate (AMC); Cefazolin (CFZ); Cefotaxime (CTX); Imipenem (IPM); Fosfomycin (FOF); Ciprofloxacin (CIP); Nalidixic Acid (NAL); Nitrofurantoin (NIT); Ticarcillin (TIC); Ticarcillin-Clavulanate (TIM); Piperacillin (PIP); Ceftazidime (CAZ); Netilmicin (NET): Tobramycin (TOB); Aztreonam (ATM); MDR (Multidrug resistance).
(-): Non-tested.

Penicillins antibiotics had the highest rate of resistance followed by cephalosporins among Gram-negative bacteria, as indicated by dark squares (Figure 3). Moreover, the lowest antibiotic resistance was due to aminoglycoside antibiotics.

Figure 3. Heat of the antibiotic resistance profile

Multidrug resistance profile
Almost one third of all isolated bacterial strains (31.54 ± 4.40%; 135/428) were multidrug resistant. The MDR rate was correlated to patients’ age (P<0.001). The rate of MDR was higher in Gram-negative (42.76 ± 8%; 62/145) compared to Gram-positive bacteria (25.79 ± 5.10%; 73/283) (P<0.001). In addition, the number of MDR isolates was higher in Enterobacteriaceae (MDR > 44%) compared to Pseudomonas spp. (MDR < 9%) (P=0.004). The MDR rate did not vary with the sampling years (P=0.42).


The antibiotic resistance limits the choice of antibiotics to treat wound infections. The frequency of these infections varied according to time and region.

The present survey was performed in an Algerian hospital located in Ain Defla district; it allowed the collection of 620 pus samples from infected wounds during five years. The number of wound infections was higher during the cold months (373/620; 60.16%) even though several studies found that infection risks increases during the warm weather.18-20 In the United States, there were 26.5% more infection cases in August than in January 20. This discrepancy could be related to the scheduling of surgeries outside the summer season in Algeria where the temperature exceeds 45°C during the summer season. Vickers et al. did not found any statistically significant relation between the climate and frequency of infections in two regions (tropical and subtropical Australian hospitals).21

The bacteriological profile of pus/wound swabs revealed that more than half of pus samples showed positive cultures (407/620; 65.65%). The rates obtained here are similar to those reported by Rai et al.22 who worked on children in Nepal (265/450; 59%) and lower than those reported by Tchakal-Mesbahi et al.23 in Algeria (79.12%; 1585 samples), Shimekaw et al.24 in Ethiopia (72.6%; 201 samples), and Kassam et al.25 in Tanzania (91.4%; 93 samples) using standard bacteriological diagnostic procedures. Despite the presence of pus and signs of wound infections, the rate of negative cultures was 34.35% (213/620). This could be due to pre-surgical antibio-prevention or early antibiotic prescription during the initial stages of infection. In addition -in these cases- bacteriological identification and antibiotic susceptibility testing are performed after therapeutic failure.

The frequency of Gram-positive (66.12%) was higher compared to Gram-negative bacteria (33.38%). This is consistent with the study of Duwadi et al. in Nepalese Tertiary Care Cancer Patients, in which the rate of Gram-positive isolates (63.9%) outnumbered Gram-negative isolates (36.1%).26 Similar results were reported also in Nepal by Upreti et al. in 182 samples from patients with clinical features of wound infection.27 A study performed in Algeria on patients with burn wound infection revealed that 68.95% of swabs contained Gram-negative bacteria (68.95%).23 The lower isolation frequency of Gram-negative bacteria can be attributed to their limited ability to survive in the dry conditions of normal skin, allowing the domination of Gram-positive bacteria.28

Escherichia coli (30.34%), K. pneumoniae (25.52%), and P. aeruginosa (23.45%) were the major bacteria among Gram-negative isolates. The same trend was reported in several regions in the world. In India, Rai et al. found that P. aeruginosa was the most common isolate (45/102; 44%) followed by K. pneumoniae (28/102; 27%) and E. coli (13/102; 13%) in wound infections among child.22 In a study performed in Tanzania by Manyahi et al., P. aeruginosa was the most frequent Gram-negative bacteria (24/147; 16.3%).29 Causative bacterial species varies according to geographic area and the wounds’ nature. In Algeria, Tchakal-Mesbahi et al. reported that P. aeruginosa was the most frequent species (33.91%) followed by K. pneumoniae (25.14%) and Acinetobacter baumanii (16.37%).23

S. aureus represented the second most frequent (27.21%) Gram-positive bacteria after CoNS. The same trend was reported in 8,569 French patients (35% and 23% for CoNS and S. aureus, respectively).10 Staphylococci are the most common colonizers bacteria of the skin and the primary causes of nosocomial infections and skin infections in the community.30

Among S. aureus isolates, 31.17% (24/77) were MRSA. Zerouki et al. found that S. aureus was isolated in 39.5% (30/76) of the Department of Orthopaedic Surgery and Traumatology, University Military Hospital of Constantine, Algeria, among them, 63.3% was MRSA.12 Also, in Algeria, Bouharkat et al. revealed that S. aureus is the most isolated species (25.97%) in diabetic patients suffering of foot infections where MRSA represented 18.3%.13 In Morocco, S. aureus rate in burn wound infections was 33.85% (44/86), MRSA represented 86.36% of them.31 These discrepancy between studies can be explained mainly by the microbial ecology of the hospitals.12 The high prevalence of S. aureus is expected since this species belongs to the normal flora of healthy persons’ skins.32

In the present study, the rate of penicillin resistance was 70.13% for S. aureus. In Morocco, the highest rate was noted for S. aureus (86.36%).31 According to Que et al., penicillinase production is the most common mechanism liable for the emergence of penicillin resistance where the prevalence is close to 80% between hospitals and the community.33

A high level of amoxicillin resistance was found in E. coli (86.36%), K. pneumoniae (97.30%), and other Enterobacteriaceae species. In addition, the combination amoxicillin-clavulanate has very important resistance (68.18 and 83.78% for E. coli and K. pneumoniae, respectively). Furthermore, El Hamzaoui et al. found that more than 80% of the different strains were resistant to this antibiotics association.31 The most common reason for resistance to b-lactam antibiotics among Enterobacteriaceae is the expression of b-lactamase enzymes that hydrolyse the b-lactam ring, resulting in antibiotic inactivation.34,35

In the present study, we get favourable clinical responses to treatments with vancomycin against Gram-positive infection. In Ethiopia, Mama et al. reported that all the 145 isolates were sensitive to vancomycin.36 This is a glycopeptide antibiotic used as last-resort treatment against resistant infections. Several generations of vancomycin were developed to prevent conceivable resistance,37 they are only used in hospitals and is administered intravenously.38

Amikacin and imipenem were the effective against Gram-negative bacteria. Both of them are expensive, they have only clinical use. Amikacin is characterized by a high level of resistance to bacterial enzyme modifications; as a result, several Gram-negative bacteria are susceptible to this antibiotic.39

The high rate of antibiotic resistance to penicillins is due to the misuse of these antibiotics. Also, the important level of resistance to the cephalosporins antibiotic can be related to their frequent used in surgery.40 To limit the emergence and spread of resistance to aminoglycosides, it is imperative to minimize selective pressures that arise within hospital settings and areas with unregulated antibiotic usage. Continuous monitoring of resistance genes in humans, animals, and food sources is vital to delay the dissemination of aminoglycoside resistance.41

In the present study, 31.54% of isolated strains showed a MDR. This could delay the wound healing process and even alter the patient’s general condition causing for example septicaemia. Furthermore, this resistance reduces the therapeutic choice and increases duration of hospitalizations. In Ethiopian investigations, higher proportions of MDR were recorded from different wound types that were estimated between 80.8 and 85%.36,42 In the present study, the MDR in Gram-negative isolates represented 42.76% while 25.79% of Gram-positive bacteria were MDR. These resistance levels were lower than the findings of Duwadi et al. (60 and 40% for Gram-positive and Gram-negative bacteria, respectively).26 In addition, the MDR varied significantly with bacterial species.23,42 There was a significant correlation between age and MDR rate. This could be explained by the build-up with age, the irrational use of antibiotics, especially self-medication.


In this study, CoNS and S. aureus are the predominant bacteria isolated from pus/ wound infections from patients at Ain Defla district, North Centre Algeria. Very high resistance rate has been recorded to commonly used antibiotics like amoxicillin (more than 80% for the different bacterial species). Amikacin and vancomycin were the most effective against Gram-negative and positive bacteria, respectively. Almost one-third of the isolates were multidrug resistant. This resistance was higher among Gram-positive bacteria. To slowdown the bacterial resistance emerging, an antibiotic susceptibility test before any antibiotic therapy is mandatory. Also, the respect of hygienic practices is necessary to prevent infections, particularly nosocomial infections. Furthermore, increasing public awareness of the risks associated with self-medications. Additional epidemiological studies are needed to perform risk analysis of antibiotic resistance in Algerian bacterial strains. Similarly, genetic background investigation is needed to understand the mechanisms of these antibiotic resistance.


The authors would like to thank Medical Staff of Makor Hamou Hospital and also acknowledge Dr. Abdellah Zibouche and his staff for their support and help in our work.

The authors declare that there is no conflict of interest.

AA and BK conceptualized the study. AA performed laboratory work, software and formal analysis. AA, RK and MA applied methodology. AA wrote the manuscript.RK and BK reviewed the manuscript. RK and BK supervised and administered the project. All authors read and approved the final manuscript for publication.


All datasets generated or analysed during this study are included in the manuscript.

This study was approved by the Institutional Ethics Committee, Algerian legislation and LBRA’s laboratory with reference number 303/PG-ISV/2015.

Written informed consent was obtained from the participants before enrolling in the study.

  1. Tanwar J, Das S, Fatima Z, Hameed S. Multidrug resistance: An emerging crisis. Interdiscip Perspect Infect Dis. 2014;541340.
  2. Vivas R, Barbosa AAT, Dolabela SS, Jain S. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. Microb Drug Resist. 2019;25(6):890-908.
  3. Alkofide H, Alhammad AM, Alruwaili A, et al. Multidrug-resistant and extensively drugresistant enterobacteriaceae: Prevalence, treatments, and outcomes – a retrospective cohort study. Infect Drug Resist. 2020;13:4653-4662.
  4. Sudhaharan S, Kanne P, Chavali P, Vemu L. Aerobic bacteriological profile and antimicrobial susceptibility pattern of pus isolates from tertiary care hospital in India. J Infect Dev Ctries. 2018;12(10):842-848.
  5. Poggio JL. Perioperative strategies to prevent surgical-site infection. Clin Colon Rectal Surg. 2013;26(3):168-173.
  6. Granick MS, Gamelli RL. Surgical Wound Healing and Management. 1st Editio. (Granick MS, Gamelli RL, eds.). CRC Press; 2007.
  7. Hemmati H, Hasannejad-Bibalan M, Khoshdoz S, et al. Two years study of prevalence and antibiotic resistance pattern of Gram-negative bacteria isolated from surgical site infections in the North of Iran. BMC Res Notes. 2020;13(1):383.
  8. Kalita JM, Nag VL, Kombade S, Yedale K. Multidrug resistant superbugs in pyogenic infections: A study from Western Rajasthan, India. Pan Afr Med J. 2021;38:409.
  9. Guo S, DiPietro LA. Factors Affecting Wound Healing. J Dent Res. 2010;89(3):219-229. Crossref
  10. Cossin S, Malavaud S, Jarno P, et al. Surgical site infection after valvular or coronary artery bypass surgery: 2008-2011 French SSI national ISO-RAISIN surveillance. J Hosp Infect. 2015;91(3):225-230.
  11. Ahmed MI. Prevalence of nosocomial wound infection among postoperative patients and antibiotics patterns at teaching hospital in Sudan. N Am J Med Sci. 2012;4(1):29-34.
  12. Zerouki A, Abada S, Tali-Maamar H, Rahal K, Naim M. Characterization of methicillin-resistant Staphylococcus aureus strains isolated from surgical site infections in orthopedic and trauma surgery in an Algerian hospital. Rev Chir Orthop Traumatol. 2015;101(2):176-180.
  13. Bouharkat B, Tir Touil A, Mullie C, Chelli N, Meddah B. Bacterial ecology and antibiotic resistance mechanisms of isolated resistant strains from diabetic foot infections in the north west of Algeria. J Diabetes Metab Disord. 2020;19(2):1261-1271.
  14. Zabaglo M, Sharman T. Postoperative Wound Infection. In: (FL) TI, ed. StatPearls [Internet]. StatPearls Publishing; 2022.
  15. CLSI Clinical and Laboratory Standards Institute. M100-S25 Performance Standards for Antimicrobial Suceptibility Testing.; 2015.
  16. Magiorakos A, Srinivasan A, Carey RB, et al. Bacteria/ : an International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin Microbiol Infect. 2012;18(3):268-281.
  17. Schwartz D. Methodes statistiques a l’usage des medecins et des biologistes. Flammarion. 1993;3:314.
  18. Gruskay J, Smith J, Kepler CK, et al. The seasonality of postoperative infection in spine surgery. J Neurosurg Spine. 2013;18(1):57-62.
  19. Kao HK, Chen MC, Lee WC, Yang WE, Chang CH, Chang Y. Seasonal temperature and pin site care regimen affect the incidence of pin site infection in pediatric supracondylar humeral fractures. Biomed Res Int. 2015;838913.
  20. Anthony CA, Peterson RA, Polgreen LA, Sewell DK, Polgreen PM. The seasonal variability in surgical site infections and the association with warmer weather: A population-based investigation. Infect Control Hosp Epidemiol. 2017;38(7):809-816.
  21. Vickers ML, Ballard EL, Harris PNA, et al. Bacterial profile, multi-drug resistance and seasonality following lower limb orthopaedic surgery in tropical and subtropical australian hospitals: An epidemiological cohort study. Int J Environ Res Public Health. 2020;17(2):657.
  22. Rai S, Yadav UN, Pant ND, et al. Bacteriological Profile and Antimicrobial Susceptibility Patterns of Bacteria Isolated from Pus/Wound Swab Samples from Children Attending a Tertiary Care Hospital in Kathmandu, Nepal. Int J Microbiol. 2017;2529085.
  23. Tchakal-Mesbahi A, Abdouni MA, Metref M. Prevalence of multidrug-resistant bacteria isolated from burn wounds in Algeria. Ann Burns Fire Disasters. 2021;34(2):150-156.
  24. Shimekaw M, Tigabu A, Tessema B. Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Risk Factors Among Patients With Wound Infections at Debre Markos Referral Hospital, Northwest, Ethiopia. Int J Low Extrem Wounds. 2022;21(2):182-192.
  25. Kassam NA, Damian DJ, Kajeguka D, Nyombi B, Kibiki GS. Spectrum and antibiogram of bacteria isolated from patients presenting with infected wounds in a Tertiary Hospital, northern Tanzania. BMC Res Notes. 2017;10(1):757.
  26. Duwadi K, Khadka S, Adhikari S, Sapkota S, Shrestha P. Bacterial Etiology of Wound Exudates in Tertiary Care Cancer Patients and Antibiogram of the Isolates. Infect Dis Res Treat. 2020;13:1178633720952077.
  27. Upreti N, Rayamajhee B, Sherchan SP, Choudhari MK, Banjara MR. Prevalence of methicillin resistant Staphylococcus aureus, multidrug resistant and extended spectrum b-lactamase producing gram negative bacilli causing wound infections at a tertiary care hospital of Nepal. Antimicrob Resist Infect Control. 2018;7(1):121.
  28. Chiller K, Selkin BA, Murakawa GJ. Skin Micro¯ora and Bacterial Infections of the Skin. J Investig Dermatol Symp Proc. 2001;6(3):170-174.
  29. Manyahi J, Matee MI, Majigo M, Moyo S, Mshana SE, Lyamuya EF. Predominance of multi-drug resistant bacterial pathogens causing surgical site infections in Muhimbili national hospital, Tanzania. BMC Res Notes. 2014;7(1):500.
  30. Otto M. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol. 2010;5(2):183-195.
  31. El Hamzaoui N, Barguigua A, Larouz S, Maouloua M. Epidemiology of burn wound bacterial infections at a Meknes hospital , Morocco. New Microbes New Infect. 2020;38:100764.
  32. Taylor T, Unakal C. Staphylococcus aureus. In: (FL): TI, ed. StatPearls Publushing; 2022.
  33. Que YA, Moreillon P. Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome). In: Elsevier, ed. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. ; 2020:2393-2431. Accessed August 23, 2022.
  34. Partridge SR. Resistance mechanisms in Enterobacteriaceae. Pathology. 2015;47(3):276-284.
  35. Alfei S, Schito AM. ג-Lactam Antibiotics and ג-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources. Pharmaceuticals. 2022;15(4):476.
  36. Mama M, Abdissa A, Sewunet T. Antimicrobial susceptibility pattern of bacterial isolates from wound infection and their sensitivity to alternative topical agents at Jimma University Specialized Hospital, South-West Ethiopia. Ann Clin Microbiol Antimicrob. 2014;13(1):14.
  37. Muhlberg E, Umstatter F, Kleist C, Domhan C, Mier W, Uhl P. Renaissance of vancomycin: Approaches for breaking antibiotic resistance in multidrug-resistant bacteria. Can J Microbiol. 2020;66(1):11-16.
  38. Bruniera FR, Ferreira FM, Saviolli LRM, et al. The use of vancomycin with its therapeutic and adverse effects: A review. Eur Rev Med Pharmacol Sci. 2015;19(4):694-700. doi:
  39. Xiao Y, Hu Y. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China. Microb Drug Resist. 2012;18(1):42-46.
  40. Brocard E, Reveiz L, Regnaux JP, Abdala V, Ramon-Pardo P, Bueno A del R. Antibiotic prophylaxis for surgical procedures: A scoping review. Rev Panam Salud Publica. 2021;45:e62.
  41. Garneau-Tsodikovaa S, Labbyb K. Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives. Medchemcomm. 2016;7(1):11-24.
  42. Abosse S, Genet C, Derbie A. Antimicrobial Resistance Profile of Bacterial Isolates Identified from Surgical Site Infections at a Referral Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2021;31(3):635-644.

Article Metrics

Article View: 152

Share This Article

© The Author(s) 2023. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.